THE PROGNOSTIC-SIGNIFICANCE OF THE HALF-LIFE OF SERUM CA-125 IN PATIENTS RESPONDING TO CHEMOTHERAPY FOR EPITHELIAL OVARIAN-CARCINOMA

被引：62

作者：

HAWKINS, RE

ROBERTS, K

WILTSHAW, E

MUNDY, J

FRYATT, IJ

MCCREADY, VR

机构：

[1] ROYAL MARSDEN HOSP,DEPT MED,FULHAM RD,LONDON SW3 6JJ,ENGLAND

[2] ROYAL MARSDEN HOSP,DEPT NUCL MED,LONDON SW3 6JJ,ENGLAND

来源：

BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 1989年 / 96卷 / 12期

关键词：

D O I：

10.1111/j.1471-0528.1989.tb06301.x

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：1395 / 1399

页数：5

共 10 条

[1] A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER [J].

BAST, RC ;

KLUG, TL ;

STJOHN, E ;

JENISON, E ;

NILOFF, JM ;

LAZARUS, H ;

BERKOWITZ, RS ;

LEAVITT, T ;

GRIFFITHS, CT ;

PARKER, L ;

ZURAWSKI, VR ;

KNAPP, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) :883-887

[2] OVARIAN-CANCER ANTIGEN CA125 - A PROSPECTIVE CLINICAL-ASSESSMENT OF ITS ROLE AS A TUMOR-MARKER [J].

CANNEY, PA ;

MOORE, M ;

WILKINSON, PM ;

JAMES, RD .

BRITISH JOURNAL OF CANCER, 1984, 50 (06) :765-769

[3]

COX DR, 1972, J R STAT SOC B, V34, P187

[4]

HAWKINS RE, 1989, IN PRESS BR J CANCER

[5]

KLUG TL, 1984, CANCER RES, V44, P1048

[6] THE CA 125 ASSAY AS A PREDICTOR OF CLINICAL RECURRENCE IN EPITHELIAL OVARIAN-CANCER [J].

NILOFF, JM ;

KNAPP, RC ;

LAVIN, PT ;

MALKASIAN, GD ;

BEREK, JS ;

MORTEL, R ;

WHITNEY, C ;

ZURAWSKI, VR ;

BAST, RC .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1986, 155 (01) :56-60

[7]

SCHWARTZ PE, 1987, CANCER, V60, P353, DOI 10.1002/1097-0142(19870801)60:3<353::AID-CNCR2820600312>3.0.CO

[8]

2-V

[9]

THIGPEN JT, 1988, SEMIN ONCOL, V15, P16

[10] OVARIAN-CANCER - THE PROGNOSTIC VALUE OF THE SERUM HALF-LIFE OF CA125 DURING INDUCTION CHEMOTHERAPY [J].

VANDERBURG, MEL ;

LAMMES, FB ;

VANPUTTEN, WLJ ;

STOTER, G .

GYNECOLOGIC ONCOLOGY, 1988, 30 (03) :307-312

← 1 →